A/Prof Manish Patel | |||||
| Specialty | : | Urology | |||
| Interest | : | Prostate cancer | |||
| Qualification | : | MBBS, MMed, FRACS, Urologic Oncology Fellowship | |||
| Gender | : | M | |||
| Practice 1 | : | San Clinic Suite 506, 185 Fox Valley Road WAHROONGA Phone: (02) 9633-2088 Fax: (02) 9633-3672 | |||
| Practice 2 | : | Westmead Private Hospital Suite 12A, Cnr Mons & Darcy Road WESTMEAD Phone: (02) 9633-2088 Fax: (02) 9633-3672 | |||
| Profile | : | Dr Patel's urological practice is sub-specialised in the area of urological oncology. He does not practice general urology, but instead concentrates his expertise in the area of surgical management of urological cancers, as well as working-up possible malignancies such as elevated PSA, haematuria and renal masses. Dr Patel graduated from the University of NSW in 1991. He undertook his residency and general surgery training at the Royal North Shore Hospital. He then completed a Masters of Medicine (USYD) in cell biology and protein biochemistry. He then completed Advanced Urology training at Royal North Shore / Royal Newcastle and Westmead Hospitals. Following Urology Training, Dr Patel completed a 2 year Urology Oncology Fellowship at Memorial Sloan-Kettering Cancer Center, New York- A world leading cancer centre for the surgical treatment of prostate , bladder, testis and renal cancer. While in New York, Dr Patel worked with Dr Peter Scardino and Dr Harry Herr, both world leaders in prostate cancer and bladder cancer treatment. In 2003 Dr Patel returned to Sydney and began practice as a full Academic Senior Lecturer, Department of Surgery, University of Sydney. He has appointments at the Sydney Adventist Hospital, Westmead Hospital and Westmead Private Hospital. Dr Patel is the only sub-specialised urological cancer surgeon in the Western and Northern Sydney region. He is also the scientific director of the Urological Cancer Organisation of Western Sydney, chair of the education committee for the Urological Oncology Program of NSW, member of the board of surgical research for the Royal Australasian College of Surgeons, co-ordinator of urological teaching and chair of medical student assessments, University of Sydney. Member of the Prostate Cancer Foundation of Australia Scientific reference committee and member of the education and advocacy board. Dr Patel also represents Australia on the American Urological Association International Board. Dr Patel has a dedicated sub-specialised urological practice in urological cancer surgery, an area is which he has a national and international reputation. His special interests are nerve sparing radical prostatectomy and cystectomy for bladder cancer. He also offers brachytherapy and other minimally invasive treatments such as laparoscopy for the treatment of urological cancers. He has one of the largest prostate cancer and bladder cancer practices in Sydney. | |||
| Research | : | Dr Patel has been actively involved in clinical and laboratory research for over 18 years. He has been the author or co-author of over 35 peer reviewed publications as well as the co-author of a book on prostate cancer and author of book chapters. His articles are published in key urological journals as well as high impact scientific cancer journals. He is also asked to review articles for urological and cancer journals. Dr Patel has also presented his research at the major international scientific meetings in the field of urology and cancer research. He has regularly been an invited speaker both locally and abroad. Dr Patel has also trained many students in clinical and scientific research. He has supervised 2 PhD students, 3 masters students that have completed and currently another 3 masters students in addition to numerous other doctors involved in clinical research. Dr Patel has recently also submitted his PhD at the University of Sydney- on New Treatments for Prostate Cancer. Current laboratory research interests include: identifying new molecular pathways in prostate cancer that can be inhibited with non-toxic drugs; the effect of herbal compounds on prostate cancer growth and the relationship between inflammation and prostate cancer development. Current clinical research includes: developing new ways to improve nerve-sparing, potency and continence after radical prostatectomy; improving management of advanced prostate cancer, decision making in men at high risk of developing prostate cancer and determining the effect of screening on prostate cancer mortality in Australia. Research is also on going on in the areas of kidney and bladder cancer. | |||



